RecruitingNCT04241328
Medtronic SYMBIOSIS Post-Market Registry for Patients Undergoing Cardiac Surgery
SYMBIOSIS Post-Market Registry
Sponsor
Medtronic Cardiac Surgery
Enrollment
5,000 participants
Start Date
Jan 9, 2020
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of this observational, multi-center prospective, post-market registry is to confirm real-world device safety and performance, to ensure the continued acceptability of identified risks, and detect emerging risks.
Eligibility
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a new treatment for people with cardiovascular diseases. The study is currently recruiting participants at 14 locations.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(14)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04241328
Related Trials
Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging
NCT076130991 location
Diabetes and Heart Disease Risk in Blacks
NCT000018531 location
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
NCT070644731149 locations
Improving the Collaborative Health of Adult Dyads
NCT053700141 location
Cerebrovascular Health and Resilience in Midlife
NCT060293481 location